Difference between revisions of "Radiosensitizers"
Jump to navigation
Jump to search
(Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...") |
Warner-admin (talk | contribs) m (Text replacement - ":Section editor transclusions|" to ":Editorial board transclusions|") |
||
| Line 3: | Line 3: | ||
[[#top|Back to Top]] | [[#top|Back to Top]] | ||
</div> | </div> | ||
| − | {{#lst: | + | {{#lst:Editorial board transclusions|radonc}} |
{{TOC limit|limit=3}} | {{TOC limit|limit=3}} | ||
[[Category:General reference pages]] | [[Category:General reference pages]] | ||
[[Category:Radiation oncology pages]] | [[Category:Radiation oncology pages]] | ||
Latest revision as of 20:22, 11 August 2023
| Associate editor | |
|---|---|
 |
Danielle S. Bitterman, MD Dana-Farber Cancer Institute Boston, MA, USA |